Literature DB >> 24074580

Cellular bioenergetics, caspase activity and glutathione in murine lungs infected with influenza A virus.

Ahmed R Alsuwaidi1, Saeeda Almarzooqi, Alia Albawardi, Sheela Benedict, Jose Kochiyil, Farah Mustafa, Stacey M Hartwig, Steven M Varga, Abdul-Kader Souid.   

Abstract

Inhibition of cellular respiration, oxidation of glutathione and induction of apoptosis have been reported in epithelial cells infected in vitro with influenza A virus (IAV). Here, the same biomarkers were investigated in vivo by assessing the lungs of BALB/c mice infected with IAV. Cellular respiration declined on day 3 and recovered on day 7 post-infection. For days 3-5, the rate (mean±SD) of respiration (µMO2min(-1)mg(-1)) in uninfected lungs was 0.103±0.021 (n=4) and in infected lungs was 0.076±0.025 (n=4, p=0.026). Relative cellular ATP (infected/uninfected) was 4.7 on day 2 and 1.07 on day 7. Intracellular caspase activity peaked on day 7. Cellular glutathione decreased by ≥10% on days 3-7. Lung pathology was prominent on day 3 and caspase-3 labeling was prominent on day 5. IAV infection was associated with suppression of cellular respiration, diminished glutathione, and induction of apoptosis. These functional biomarkers were associated with structural changes noted in infected mice.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Caspase-3; Cellular ATP; Cellular bioenergetics; Cellular glutathione; Cellular respiration; Influenza A virus

Mesh:

Substances:

Year:  2013        PMID: 24074580     DOI: 10.1016/j.virol.2013.07.034

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection.

Authors:  Nicholas S Heaton; Natasha Moshkina; Romain Fenouil; Thomas J Gardner; Sebastian Aguirre; Priya S Shah; Nan Zhao; Lara Manganaro; Judd F Hultquist; Justine Noel; David Sachs; Jennifer Hamilton; Paul E Leon; Amit Chawdury; Shashank Tripathi; Camilla Melegari; Laura Campisi; Rong Hai; Giorgi Metreveli; Andrea V Gamarnik; Adolfo García-Sastre; Benjamin Greenbaum; Viviana Simon; Ana Fernandez-Sesma; Nevan J Krogan; Lubbertus C F Mulder; Harm van Bakel; Domenico Tortorella; Jack Taunton; Peter Palese; Ivan Marazzi
Journal:  Immunity       Date:  2016-01-19       Impact factor: 31.745

2.  A universal mammalian vaccine cell line substrate.

Authors:  Jackelyn Murray; Kyle V Todd; Abhijeet Bakre; Nichole Orr-Burks; Les Jones; Weilin Wu; Ralph A Tripp
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

3.  Sirolimus alters lung pathology and viral load following influenza A virus infection.

Authors:  Ahmed R Alsuwaidi; Junu A George; Saeeda Almarzooqi; Stacey M Hartwig; Steven M Varga; Abdul-Kader Souid
Journal:  Respir Res       Date:  2017-07-11

4.  Construction of a Transcriptome-Driven Network at the Early Stage of Infection with Influenza A H1N1 in Human Lung Alveolar Epithelial Cells.

Authors:  Myungguen Chung; Soo Young Cho; Young Seek Lee
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

5.  Exacerbation of Influenza A Virus Disease Severity by Respiratory Syncytial Virus Co-Infection in a Mouse Model.

Authors:  Junu A George; Shaikha H AlShamsi; Maryam H Alhammadi; Ahmed R Alsuwaidi
Journal:  Viruses       Date:  2021-08-18       Impact factor: 5.048

Review 6.  Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host Interaction.

Authors:  Sandra Söderholm; Yu Fu; Lana Gaelings; Sergey Belanov; Laxman Yetukuri; Mikhail Berlinkov; Anton V Cheltsov; Simon Anders; Tero Aittokallio; Tuula A Nyman; Sampsa Matikainen; Denis E Kainov
Journal:  Viruses       Date:  2016-09-29       Impact factor: 5.048

Review 7.  Ferroptosis in viral infection: the unexplored possibility.

Authors:  Mao-Peng Wang; Banda Joshua; Ning-Yi Jin; Shou-Wen Du; Chang Li
Journal:  Acta Pharmacol Sin       Date:  2021-12-06       Impact factor: 7.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.